New chiral cis‐dioxidomolybdenum compounds [MoO2(acac)(RN,O)] [R = Bn (1), pic (2)] and [{MoO2(acac)}2{μ‐(O,N,N,O)}] (3) have been synthesized by treating [MoO2(acac)2] withthe corresponding enantiomerically pure alcohol‐iminocompounds derived from (+)‐α‐pinene modification, (RN,OH) (R = Bn, pic) and (HO,N,N,OH), respectively. Compound [MoO2Cl2(O,N,N,O)] (4) has also been prepared. All the compounds were fully characterized both in solution and in the solid state, including by single‐crystal X‐ray diffraction analysis of enantiomerically pure 3. DFT studies support the stereoselectivity of the synthesis of compound 3. Catalytic olefin epoxidation studies were performed with cis‐cyclooctene, (R)‐limonene, and trans‐β‐methylstyrene by using derivatives 1–4 as catalyst precursors and tert‐butyl hydroperoxide (TBHP) or H2O2 as oxidant. All the catalytic systems showed high chemoselectivity irrespective of the terminal oxidant used. The molybdenum compounds exhibited medium to high catalytic activity at mild reaction temperatures, but no substantial optical induction was observed. This study represents the first use of chiral monoacetylacetonato‐cis‐dioxidomolybdenum compounds as homogeneous olefin epoxidation catalysts.
The mixed disilyl-substituted cyclopentadiene C 5 H 4 [SiMe 2 (CH=CHCH 3 )](SiMe 3 ) (2) has been synthesized in a onepot reaction by alkylation, deprotonation and silylation of
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.